These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 29617684

  • 1. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C, Supasitthumrong T, Tangwongchai S, Hemrunroj S, Chuchuen P, Tawankanjanachot I, Likitchareon Y, Phanthumchinda K, Sriswasdi S, Maes M.
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I, Illán-Gala I, Alcolea D, Sánchez-Saudinós MB, Salgado SA, Morenas-Rodríguez E, Subirana A, Videla L, Clarimón J, Carmona-Iragui M, Ribosa-Nogué R, Blesa R, Fortea J, Lleó A.
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [Abstract] [Full Text] [Related]

  • 3. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchhardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J.
    Alzheimers Res Ther; 2017 Oct 10; 9(1):84. PubMed ID: 29017593
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC, Jaimes-Barragán F, Henao E, Tirado V, Muñoz C, Reiman EM, Tariot PN, Langbaum JB, Lopera F.
    Int Psychogeriatr; 2016 Mar 10; 28(3):503-10. PubMed ID: 26478578
    [Abstract] [Full Text] [Related]

  • 5. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.
    Acta Neurol Scand; 2005 Mar 10; 111(3):172-9. PubMed ID: 15691286
    [Abstract] [Full Text] [Related]

  • 6. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T, Hänninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H.
    J Alzheimers Dis; 2014 Mar 10; 39(3):679-90. PubMed ID: 24246420
    [Abstract] [Full Text] [Related]

  • 7. CERAD-neuropsychological battery in screening mild Alzheimer's disease.
    Sotaniemi M, Pulliainen V, Hokkanen L, Pirttilä T, Hallikainen I, Soininen H, Hänninen T.
    Acta Neurol Scand; 2012 Jan 10; 125(1):16-23. PubMed ID: 21198445
    [Abstract] [Full Text] [Related]

  • 8. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S, Schönknecht P, Pantel J, Schröder J.
    Fortschr Neurol Psychiatr; 2005 Oct 10; 73(10):568-76. PubMed ID: 16217697
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S, Herde L, Preische O, Zeller A, Heymann P, Robens S, Elbing U, Laske C.
    Sci Rep; 2019 Mar 05; 9(1):3543. PubMed ID: 30837580
    [Abstract] [Full Text] [Related]

  • 10. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).
    Beck IR, Gagneux-Zurbriggen A, Berres M, Taylor KI, Monsch AU.
    Arch Clin Neuropsychol; 2012 Aug 05; 27(5):510-9. PubMed ID: 22718104
    [Abstract] [Full Text] [Related]

  • 11. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA, Cortés-Martínez A, Valles-Salgado M, Rognoni T, Fernández-Matarrubia M, Moreno-Ramos T, Matías-Guiu J.
    Int Psychogeriatr; 2017 Jan 05; 29(1):105-113. PubMed ID: 27682860
    [Abstract] [Full Text] [Related]

  • 12. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M, Laatu S, Martikainen K, Marttila R.
    Acta Neurol Scand; 2013 Dec 05; 128(6):409-13. PubMed ID: 23668316
    [Abstract] [Full Text] [Related]

  • 13. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF, Bronzini A, Tolentino ES, Medyk C, Schultz-Pereira GL.
    Arq Neuropsiquiatr; 2018 Mar 05; 76(3):145-149. PubMed ID: 29809231
    [Abstract] [Full Text] [Related]

  • 14. A total score for the CERAD neuropsychological battery.
    Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, Weiner MF, Cullum CM.
    Neurology; 2005 Jul 12; 65(1):102-6. PubMed ID: 16009893
    [Abstract] [Full Text] [Related]

  • 15. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S, Supasitthumrong T, Hemrunroj S, Tunvirachaisakul C, Chuchuen P, Houngngam N, Snabboon T, Tawankanjanachot I, Likitchareon Y, Phanthumchindad K, Maes M.
    Mol Neurobiol; 2018 Aug 12; 55(8):6449-6462. PubMed ID: 29307083
    [Abstract] [Full Text] [Related]

  • 16. A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.
    Gu D, Lv X, Shi C, Zhang T, Liu S, Fan Z, Tu L, Zhang M, Zhang N, Chen L, Wang Z, Wang J, Zhang Y, Li H, Wang L, Zhu J, Zheng Y, Wang H, Yu X, Alzheimer's Disease Neuroimaging Initiative (ADNI)see Acknowledgements, ..
    J Med Internet Res; 2023 Dec 01; 25():e49147. PubMed ID: 38039074
    [Abstract] [Full Text] [Related]

  • 17. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S, Tangwongchai S, Charoenboon T, Panasawat M, Supasitthumrong T, Chaipresertsud P, Maleevach P, Likitjaroen Y, Phanthumchinda K, Maes M.
    Dement Geriatr Cogn Disord; 2021 Dec 01; 50(2):183-194. PubMed ID: 34325427
    [Abstract] [Full Text] [Related]

  • 18. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH, Park H, Sohn SW, Kim S, Park KW.
    Geriatr Gerontol Int; 2017 Oct 01; 17(10):1603-1609. PubMed ID: 27910252
    [Abstract] [Full Text] [Related]

  • 19. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A, Adam S, Van der Linden M, Salmon E, Juillerat AC, Mulligan R, Seron X.
    J Neurol; 2005 Jan 01; 252(1):47-55. PubMed ID: 15654553
    [Abstract] [Full Text] [Related]

  • 20. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
    Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J.
    Neurology; 2012 Feb 07; 78(6):379-86. PubMed ID: 22238414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.